-
公开(公告)号：US20170227528A1
公开(公告)日：2017-08-10
申请号：US15515501
申请日：2014-09-30
发明人： Qiang Feng , Zhipeng Liu , Nan Meng , Jun Wang
CPC分类号： G01N33/5091 , G01N30/02 , G01N30/62 , G01N30/72 , G01N33/48 , G01N2030/027 , G01N2800/324
摘要： The present invention relates to a disease-specific metabolite profile, and particularly to a biomarker composition obtained by screening from blood plasma-specific profiles of coronary heart disease subjects. The present invention also relates to a use of the biomarker compositions in risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease, and to a method for risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease. The biomarker composition as provided by the present invention can be used for early diagnosis of coronary heart disease and has high sensitivity, good specificity and good application prospects.
-
公开(公告)号：US20170234852A1
公开(公告)日：2017-08-17
申请号：US15515513
申请日：2014-09-30
发明人： Qiang Feng , Zhipeng Liu , Nan Meng , Jun Wang
IPC分类号： G01N33/493 , G06F19/24 , G01N30/72
CPC分类号： G01N33/493 , G01N30/02 , G01N30/62 , G01N30/7233 , G01N33/48 , G01N33/6893 , G01N2570/00 , G01N2800/324 , G01N2800/50 , G01N2800/56 , G06F19/324 , G16B40/00 , G16H50/30
摘要： The present invention relates to a disease-specific metabolite profile, and particularly to a biomarker composition obtained by screening from urine-specific metabolite profiles of coronary heart disease subjects. The present invention also relates to a use of the biomarker compositions in risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease, and to a method for risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease. The biomarker composition as provided by the present invention can be used for early diagnosis of coronary heart disease and has high sensitivity, good specificity and good application prospects.
-
公开(公告)号：US10526659B2
公开(公告)日：2020-01-07
申请号：US15017087
申请日：2016-02-05
发明人： Qiang Feng , Dongya Zhang , Longqing Tang , Jun Wang
IPC分类号： C12Q1/68 , C07H21/04 , C12Q1/6886 , C12Q1/6806
摘要： Biomarkers and methods related to microbiota for predicting the risk of a disease, particularly colorectal cancer (CRC), are described.
-
公开(公告)号：US10100360B2
公开(公告)日：2018-10-16
申请号：US14418800
申请日：2013-06-05
发明人： Shenghui Li , Qiang Feng , Zhuye Jie , Dongya Zhang , Junjie Qin , Jun Wang , Jian Wang , Huanming Yang
IPC分类号： C12Q1/68 , G06F19/22 , G16H50/20 , C12Q1/6883
摘要： Biomarkers for diabetes and usages thereof are provided. And the biomarkers are nucleotides having polynucleotide sequences defined in SEQ ID NOs: 1-50.
-
公开(公告)号：US20150292011A1
公开(公告)日：2015-10-15
申请号：US14418800
申请日：2013-06-05
发明人： Shenghui Li , Qiang Feng , Zhuye Jie , Dongya Zhang , Junjie Qin , Jun Wang , Jian Wang , Huanming Yang
CPC分类号： C12Q1/6883 , C12Q2600/112 , C12Q2600/156 , C12Q2600/158 , G06F19/22 , G16H50/20
摘要： Biomarkers for diabetes and usages thereof are provided. And the biomarkers are nucleotides having polynucleotide sequences defined in SEQ ID NOs: 1-50.
摘要翻译： 提供糖尿病生物标记物及其用途。 并且生物标志物是具有SEQ ID NO：1-50中定义的多核苷酸序列的核苷酸。
-
6.发明申请USE OF ROSEBURIA IN THE PREVENTION AND TREATMENT FOR OBESITY RELATED DISEASES 审中-公开ROSEBURIA在预防和治疗肥胖相关疾病中的应用公开(公告)号：US20150037286A1
公开(公告)日：2015-02-05
申请号：US14516373
申请日：2014-10-16
发明人： Junjie Qin , Shenghui Li , Jianfeng Zhu , Xiaoping Li , Suisha Liang , Jun Wang , Jian Wang , Huanming Yang , Qiang Feng
CPC分类号： A61K35/74 , A23L33/135 , A23V2002/00 , A61K9/19 , C12N1/20 , Y02A50/481
摘要： The present invention provides use of Roseburia in the preparation of composition for prevention and/or treatment of obesity related diseases. Also provided are a composition used in the treatment and prevention for obesity related diseases, comprising pharmaceutical, drink, food, and/or animal feed composition, etc; and a method of reducing body weight and/or blood glucose.
摘要翻译： 本发明提供玫瑰红利用于预防和/或治疗肥胖相关疾病的组合物的制备中的用途。 还提供了用于治疗和预防肥胖相关疾病的组合物，包括药物，饮料，食物和/或动物饲料组合物等; 以及降低体重和/或血糖的方法。
-
公开(公告)号：US20180339034A1
公开(公告)日：2018-11-29
申请号：US15755926
申请日：2016-03-21
申请人： BGI Shenzhen
发明人： Qiang Feng , Wenbin Xue , Yuanqiang Zou , Xiaoping Li , Chuan Liu , Xin Li
摘要： Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
-
公开(公告)号：US20180334703A1
公开(公告)日：2018-11-22
申请号：US15546264
申请日：2015-01-27
申请人： BGI SHENZHEN
发明人： Qiang Feng , Mo Han , Liang Xiao , Jun Wang
IPC分类号： C12Q1/6806 , A01N1/02 , C07D213/16
CPC分类号： C12Q1/6806 , A01N1/0205 , C07D213/16 , C07D213/20 , C12N9/96
摘要： Disclosed are a stabilizer for storage of a biological sample, a composition for storage of a nucleic acid and/or a polypeptide in a biological sample under non-freezing conditions, a kit comprising the composition, a mixture comprising the composition and a biological sample, and a method for storage of a nucleic acid and/or a polypeptide in a biological sample under non-freezing conditions. The integrity and stability of the nucleic acid and/or polypeptide in a biological sample can be stored for a long time under non-freezing conditions by using the stabilizer according to the invention, and therefore the stabilizer has a good application prospect.
-
公开(公告)号：US11033614B2
公开(公告)日：2021-06-15
申请号：US15755926
申请日：2016-03-21
申请人： BGI Shenzhen
发明人： Qiang Feng , Wenbin Xue , Yuanqiang Zou , Xiaoping Li , Chuan Liu , Xin Li
IPC分类号： A61K39/08 , C12N1/20 , A61K35/741 , A61K9/00
摘要： Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
-
公开(公告)号：US20210170009A1
公开(公告)日：2021-06-10
申请号：US17174053
申请日：2021-02-11
申请人： BGI Shenzhen
发明人： Qiang Feng , Wenbin Xue , Yuanqiang Zou , Xiaoping Li , Chuan Liu , Xin Li
IPC分类号： A61K39/08 , C12N1/20 , A61K9/00 , A61K35/741
摘要： Provided is an application of Butyribacter intestini in the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.019 秒)
